RxDoctor Payments Data

Robert Allen

Internal Medicine · Salisbury, MDNPI 1578533584

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 90 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 20 manufacturers reported payments, led by Novo Nordisk at 29.5% of the total.

$1,258in general payments, 2019–2025

Across 90 payments — averaging $13.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$372
  • AstraZeneca$149
  • Lilly USA, LLC$98
  • AbbVie$88
  • Boehringer Ingelheim$77
  • Biohaven Pharmaceuticals, Inc.$67
  • plus $407 from 14 others

What the payments were for

  • Food & beverage$1,258100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,258 in reported general payments places this provider in the 75th percentile of 2,979 internal medicine providers in Maryland.

See all internal medicine providers in Maryland →

Other internal medicine in Salisbury

See the full list for Maryland →

Where these figures come from

Is this you, or does something look wrong? →